Improving in the Fasting, but Not the Postprandial, Glucose Level is Associated with Reduction of Plasma d-ROMs Level in Patients with Type 2 Diabetes

Aims: This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. Methods: As the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission....

Full description

Saved in:
Bibliographic Details
Published inJournal of Nippon Medical School Vol. 80; no. 3; pp. 200 - 210
Main Authors Ohara, Makoto, Watanabe, Kentaro, Suzuki, Tatsuya, Sekimizu, Ken-ichi, Motoyama, Masayuki, Ishii, Kazuhito, Sawai, Keisuke, Nakano, Hiroshi, Oba, Kenzo, Mizuno, Kyoichi
Format Journal Article
LanguageEnglish
Published Japan The Medical Association of Nippon Medical School 2013
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Aims: This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. Methods: As the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission. Then, after treatment to lower plasma glucose levels, the second daily profile of these levels was evaluated. Fasting plasma glucose (FPG), the total area under the curve (AUC) of the daily plasma glucose profile (AUCDP), the AUC of the postprandial plasma glucose levels (AUCPP), the AUC of the daily plasma d-ROMs profile (AUCd-ROMs), the coefficient of variation (CV) of plasma glucose (CVPG), and the mean amplitude of glycemic excursions (MAGE) were calculated. The relationship between the improvement of glucose metabolism and that of oxidative stress in patients with type 2 diabetes was evaluated. Results: The second determinations of FPG, AUCDP, AUCPP, MAGE, and AUCd-ROMs were significantly lower than those of the first determinations, but no significant difference was observed in CVPG. Linear regression analysis demonstrated significant associations between the changes in AUCd-ROMs and the changes in both FPG and AUCDP, whereas no significant association was observed between the change in AUCd-ROMs and the change in AUCPP, CVPG, or MAGE. Conclusions: This study has demonstrated that improvement of the FPG level, but not of the postprandial glucose level, is associated with a reduction of the plasma level of d-ROMs in patients with type 2 diabetes.
AbstractList AIMSThis study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. METHODSAs the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission. Then, after treatment to lower plasma glucose levels, the second daily profile of these levels was evaluated. Fasting plasma glucose (FPG), the total area under the curve (AUC) of the daily plasma glucose profile (AUCDP), the AUC of the postprandial plasma glucose levels (AUCPP), the AUC of the daily plasma d-ROMs profile (AUCd-ROMs), the coefficient of variation (CV) of plasma glucose (CVPG), and the mean amplitude of glycemic excursions (MAGE) were calculated. The relationship between the improvement of glucose metabolism and that of oxidative stress in patients with type 2 diabetes was evaluated. RESULTSThe second determinations of FPG, AUCDP, AUCPP, MAGE, and AUCd-ROMs were significantly lower than those of the first determinations, but no significant difference was observed in CVPG. Linear regression analysis demonstrated significant associations between the changes in AUCd-ROMs and the changes in both FPG and AUCDP, whereas no significant association was observed between the change in AUCd-ROMs and the change in AUCPP, CVPG, or MAGE. CONCLUSIONSThis study has demonstrated that improvement of the FPG level, but not of the postprandial glucose level, is associated with a reduction of the plasma level of d-ROMs in patients with type 2 diabetes.
This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. As the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission. Then, after treatment to lower plasma glucose levels, the second daily profile of these levels was evaluated. Fasting plasma glucose (FPG), the total area under the curve (AUC) of the daily plasma glucose profile (AUCDP), the AUC of the postprandial plasma glucose levels (AUCPP), the AUC of the daily plasma d-ROMs profile (AUCd-ROMs), the coefficient of variation (CV) of plasma glucose (CVPG), and the mean amplitude of glycemic excursions (MAGE) were calculated. The relationship between the improvement of glucose metabolism and that of oxidative stress in patients with type 2 diabetes was evaluated. The second determinations of FPG, AUCDP, AUCPP, MAGE, and AUCd-ROMs were significantly lower than those of the first determinations, but no significant difference was observed in CVPG. Linear regression analysis demonstrated significant associations between the changes in AUCd-ROMs and the changes in both FPG and AUCDP, whereas no significant association was observed between the change in AUCd-ROMs and the change in AUCPP, CVPG, or MAGE. This study has demonstrated that improvement of the FPG level, but not of the postprandial glucose level, is associated with a reduction of the plasma level of d-ROMs in patients with type 2 diabetes.
Aims: This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in patients with type 2 diabetes. Methods: As the first daily profile, the plasma levels of glucose and d-ROMs were determined on admission. Then, after treatment to lower plasma glucose levels, the second daily profile of these levels was evaluated. Fasting plasma glucose (FPG), the total area under the curve (AUC) of the daily plasma glucose profile (AUCDP), the AUC of the postprandial plasma glucose levels (AUCPP), the AUC of the daily plasma d-ROMs profile (AUCd-ROMs), the coefficient of variation (CV) of plasma glucose (CVPG), and the mean amplitude of glycemic excursions (MAGE) were calculated. The relationship between the improvement of glucose metabolism and that of oxidative stress in patients with type 2 diabetes was evaluated. Results: The second determinations of FPG, AUCDP, AUCPP, MAGE, and AUCd-ROMs were significantly lower than those of the first determinations, but no significant difference was observed in CVPG. Linear regression analysis demonstrated significant associations between the changes in AUCd-ROMs and the changes in both FPG and AUCDP, whereas no significant association was observed between the change in AUCd-ROMs and the change in AUCPP, CVPG, or MAGE. Conclusions: This study has demonstrated that improvement of the FPG level, but not of the postprandial glucose level, is associated with a reduction of the plasma level of d-ROMs in patients with type 2 diabetes.
Author Sekimizu, Ken-ichi
Ohara, Makoto
Motoyama, Masayuki
Ishii, Kazuhito
Suzuki, Tatsuya
Mizuno, Kyoichi
Sawai, Keisuke
Oba, Kenzo
Watanabe, Kentaro
Nakano, Hiroshi
Author_xml – sequence: 1
  fullname: Ohara, Makoto
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 2
  fullname: Watanabe, Kentaro
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 3
  fullname: Suzuki, Tatsuya
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 4
  fullname: Sekimizu, Ken-ichi
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 5
  fullname: Motoyama, Masayuki
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 6
  fullname: Ishii, Kazuhito
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 7
  fullname: Sawai, Keisuke
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 8
  fullname: Nakano, Hiroshi
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 9
  fullname: Oba, Kenzo
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
– sequence: 10
  fullname: Mizuno, Kyoichi
  organization: Divisions of Cardiology, Hepatology, Geriatrics, and Integrated Medicine, Department of Internal Medicine, Graduate School of Medicine, Nippon Medical School
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23832404$$D View this record in MEDLINE/PubMed
BookMark eNo9kUlP3EAQhVuIiC2cco_6GCl40ovXSyREAkGahBGCs1XuLjM9srsHV5uIP8LvxTDDnGr76h3eO2b7Pnhk7IsUM6kK9WPle5qVYqaE2GNHUqdFolNR7b_3WZLmRX7IjolWQmidZfkBO1S61CoV6RF7ue7XQ3hy_oE7z-MS-SVQnMYz3oyR_wvxfbkIFNcDeOugO-NX3WgCIZ_jE3bcET8nCsZBRMv_u7jkt2hHE13wPLR80QH1wG1ye_OXPn48X0B06CNtPu6e18gV_-WgwYj0mX1qoSM83dYTdn_5--7iTzK_ubq-OJ8nJi1kTIoMRFaVqkEEm9vWCqhKnatGaRCVNKIAaSFHpVtps1RjlbcmN9nki250WegT9m2jO5nwOCLFundksOvAYxiplrqqRFYKkU7o9w1qhkA0YFuvB9fD8FxLUb8FUb8FUZeinoKY6K9b4bHp0e7YD-cn4OcGWFGEB9wBMERnOtyJ6a3i7mCWMNTo9Sv6dJ00
CitedBy_id crossref_primary_10_1016_j_ajem_2020_08_059
Cites_doi 10.1007/s13340-010-0006-7
10.1016/S0140-6736(98)00090-7
10.1186/1476-511X-8-41
10.1385/ENDO:29:1:143
10.1016/S0045-6535(99)00296-9
10.1046/j.1365-2362.30.s2.2.x
10.1016/S0168-8227(01)00353-9
10.1161/ATVBAHA.107.152835
10.1074/jbc.R400019200
10.2337/diacare.19.3.257
10.1111/j.1447-0594.2005.00282.x
10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4
10.1016/S0140-6736(98)12131-1
10.1210/jc.2005-1566
10.1161/hc0502.103333
10.2337/db08-0063
10.5551/jat.E538
10.1111/j.1447-0594.2008.00465.x
10.1152/ajpheart.01332.2008
10.1016/0002-8703(87)90635-1
10.1056/NEJM199505043321804
10.2337/dc08-1671
10.5551/jat.E265
10.1007/s00125-009-1574-6
10.1016/j.ejphar.2011.02.044
10.1001/jama.295.14.1681
10.1038/414813a
10.1016/j.freeradbiomed.2010.09.006
10.1111/j.1365-2265.2007.03099.x
10.1016/0026-0495(94)90039-6
10.1016/j.bbrc.2006.09.039
10.1111/j.1464-5491.2005.01647.x
10.1111/j.1463-1326.2009.01037.x
10.1177/193229681100500112
10.2337/diacare.28.10.2465
10.1056/NEJM199309303291401
10.2337/diabetes.54.6.1615
10.2337/diacare.26.3.881
10.1016/j.archger.2009.09.022
10.1007/s00125-004-1334-6
10.1507/endocrj.K11E-114
10.1016/S0300-483X(00)00231-6
10.1016/j.atherosclerosis.2010.04.024
10.1007/s11745-011-3539-z
10.1016/j.diabres.2010.11.030
ContentType Journal Article
Copyright 2013 by the Medical Association of Nippon Medical School
Copyright_xml – notice: 2013 by the Medical Association of Nippon Medical School
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1272/jnms.80.200
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1347-3409
EndPage 210
ExternalDocumentID 10_1272_jnms_80_200
23832404
article_jnms_80_3_80_200_article_char_en
Genre Journal Article
GroupedDBID .55
29L
2WC
53G
5GY
7.U
ABDBF
ABPTK
AEGXH
AENEX
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DU5
E3Z
EBD
EBS
EJD
EMOBN
ESX
F5P
FRP
GX1
JMI
JSF
JSH
KQ8
MK0
MOJWN
M~E
RJT
RNS
RZJ
SV3
TKC
TR2
TUS
W2D
X7M
XSB
~8M
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c471t-75a05982beead6dfd0a98362b23a091c07a1da6e23f1d543e96fc6c53453b3873
ISSN 1345-4676
IngestDate Fri Apr 12 00:46:22 EDT 2024
Fri Aug 23 01:03:41 EDT 2024
Thu May 23 23:17:58 EDT 2024
Wed Apr 05 06:07:02 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c471t-75a05982beead6dfd0a98362b23a091c07a1da6e23f1d543e96fc6c53453b3873
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/jnms/80/3/80_200/_article/-char/en
PMID 23832404
PQID 1399058004
PQPubID 23479
PageCount 11
ParticipantIDs proquest_miscellaneous_1399058004
crossref_primary_10_1272_jnms_80_200
pubmed_primary_23832404
jstage_primary_article_jnms_80_3_80_200_article_char_en
PublicationCentury 2000
PublicationDate 2013-00-00
PublicationDateYYYYMMDD 2013-01-01
PublicationDate_xml – year: 2013
  text: 2013-00-00
PublicationDecade 2010
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Journal of Nippon Medical School
PublicationTitleAlternate J Nippon Med Sch
PublicationYear 2013
Publisher The Medical Association of Nippon Medical School
Publisher_xml – name: The Medical Association of Nippon Medical School
References 44. Arcaro G, Cretti A, Balzano S, et al.: Insulin causes endothelial dysfunction in humans: sites and mechanisms. Circulation 2002; 105: 576-582.
45. Choi SW, Benzie IF, Lam CS, et al.: Inter-relationships between DNA damage, ascorbic acid and glycaemic control in Type 2 diabetes mellitus. Diabet Med 2005; 22: 1347-1353.
30. Sugiura T, Dohi Y, Takase H, Yamashita S, Tanaka S, Kimura G: Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag 2011; 7: 475-482.
32. Ceriello A: The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000; 16: 125-132.
6. Morrow JD, Frei B, Longmire AW, et al.: Increase in circulating products of lipid peroxidation (f2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198-1203.
7. Robertson RP: Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279: 42351-42354.
8. Paolisso G, D'Amore A, Volpe C, et al.: Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 1994; 43: 1426-1429.
26. Cesarone MR, Belcaro G, Carratelli M, et al.: A simple test to monitor oxidative stress. Int Angiol 1999; 18: 127-130.
21. Naruse R, Takebayashi K, Morita K, Aso Y, Inukai T: Comparison of effects of insulin aspart three times a day versus insulin detemir once a day on oxidative stress in patients with type 2 diabetes. Endocr J 2011; 58: 1055-1063.
15. Monnier L, Mas E, Ginet C, et al.: Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 2006; 295: 1681-1687.
43. Tanaka A, Azuma K, Toyofuku Y, et al.: Insulin and nateglinide reduce monocyte adhesion to endothelial cells in Goto-Kakizaki rats exhibiting repetitive blood glucose fluctuation. Biochem Biophys Res Commun 2006; 350: 195-201.
5. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
22. Magata Y, Oba K, Inuzuka Y, Nakano H: Aging per se does not influence postprandial glucose levels in type 2 diabetes. Geriatr Gerontol Int 2005; 5: 146-151.
35. Nakagami T: Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin. Diabetologia 2004; 47: 385-394.
16. Siegelaar SE, Barwari T, Kulik W, Hoekstra JB, DeVries JH: No relevant relationship between glucose variability and oxidative stress in well-regulated type 2 diabetes patients. J Diabetes Sci Technol 2011; 5: 86-92.
38. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N: Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 2006; 91: 837-842.
36. The DECODE study group on behalf of the European Diabetes Epidemiology Group: Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria. Lancet 1999; 354: 617-621.
9. Matsushima S, Kinugawa S, Yokota T, et al.: Increased myocardial NAD(P)H oxidase-derived superoxide causes the exacerbation of postinfarct heart failure in type 2 diabetes. Am J Physiol Heart Circ Physiol 2009; 297: H409-H416.
13. Bunck MC, Cornàr A, Eliasson B, et al.: One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress. Atherosclerosis 2010; 212: 223-229.
42. Monnier L, Colette C, Mas E, et al.: Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy. Diabetologia 2010; 53: 562-571.
2. Evans M: The UK prospective diabetes study. Lancet 1998; 352: 1932-1933.
3. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-1625.
28. Kehrer JP: The Haber-Weiss reaction and mechanisms of toxicity. Toxicology 2000; 149: 43-50.
17. Hirose H, Kawabe H, Komiya N, Saito I: Relations between serum reactive oxygen metabolites (ROMs) and various inflammatory and metabolic parameters in a Japanese population. J Atheroscler Thromb 2009; 16: 77-82.
34. Ceriello A, Esposito K, Piconi L, et al.: Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients. Diabetes 2008; 57: 1349-1354.
47. Gianturco V, Bellomo A, D'Ottavio E, et al.: Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction? Arch Gerontol Geriatr 2009; 49 (Suppl 1): 129-133.
48. Yamaoka-Tojo M, Tojo T, Kosugi R, et al.: Effects of ezetimibe add-on therapy for high-risk patients with dyslipidemia. Lipids Health Dis 2009; 8: 41.
51. Ahmed N, Babaei-Jadidi R, Howell SK, Thornalley PJ, Beisswenger PJ: Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Diabetes Care 2005; 28: 2465-2471.
46. Kostapanos MS, Spyrou AT, Tellis CC, et al.: Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress. Lipids 2011; 46: 341-348.
50. Nagashima T, Oikawa S, Hirayama Y, et al.: Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients. Diabetes Res Clin Pract 2002; 56: 19-25.
25. Kigawa Y, Oba K, Futami-Suda S, et al.: Daily blood glucose profiles of glibenclamide and gliclazide taken once or twice daily in elderly type 2 diabetic patients. Geriatr Gerontol Int 2008; 8: 160-165.
24. Monnier L, Lapinski H, Colette C: Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c. Diabetes Care 2003; 26: 881-885.
23. Monnier L: Is postprandial glucose a neglected cardiovascular risk factor in type 2 diabetes? Eur J Clin Invest 2000; 30 (Suppl 2): 3-11.
37. Mita T, Watada H, Shimizu T, et al.: Nateglinide reduces carotid intima-media thickening in type 2 diabetic patients under good glycemic control. Arterioscler Thromb Vasc Biol 2007; 27: 2456-2462.
49. Xiang GD, Sun HL, Zhao LS, Hou J, Yue L, Xu L: The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance. Clin Endocrinol (Oxf) 2008; 68: 716-723.
40. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, DeVries JH: Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008; 51: 183-190.
31. Kotani K, Taniguchi N: The association between reactive oxygen metabolites and metabolic syndrome in asymptomatic Japanese men. J Clin Med Res 2011; 3: 247-251.
19. Seino Y, Nanjo K, Tajima N, et al.: The Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1: 2-20.
33. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
10. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB: Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med 2010; 49: 1603-1616.
29. Seino Y, Nanjo K, Tajima N, et al.: Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetol Int 2010; 1: 2-20.
20. Japanese Society of Hypertension Committee: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 2009; 32: 3-107.
14. Chen LL, Yu F, Zeng TS, Liao YF, Li YM, Ding HC: Effects of gliclazide on endothelial function in patients with newly diagnosed type 2 diabetes. Eur J Pharmacol 2011; 659: 296-301.
1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
4. Haberland ME, Fogelman AM: The role of altered lipoproteins in the pathogenesis of atherosclerosis. Am Heart J 1987; 113: 573-577.
18. Kamezaki F, Yamashita K, Kubara T, et al.: Derivatives of reactive oxygen metabolites correlates with high-sensitivity C-reactive protein. J Atheroscler Thromb 2008; 15: 206-212.
11. Mori Y, Itoh Y, Obata T, Tajima N: Effects of pioglitazone vs glibenclamide on postprandial increases in glucose and triglyceride levels and on oxidative stress in Japanese patients with type 2 diabetes. Endocrine 2006; 29: 143-148.
27. Lindsey ME, Tarr MA: Quantisation of hydroxyl radical during Fenton oxidation following a single addition of iron and peroxide. Chemosphere 2000; 41: 409-417.
41. Siegelaar SE, Kulik W, van Lenthe H, Mukherjee R, Hoekstra JB, Devries JH: A randomized clinical trial comparing the effect of basal insulin and inhaled mealtime insulin on glucose variability and oxidative stress. Diabetes Obes Metab 2009; 11: 709-714.
12. Chakraborty A, Chowdhury S, Bhattacharyya M: Effect of metformin on oxidative stress, nitrosative stress and inflammatory biomarkers in type 2 diabetes patients. Diabetes Res Clin Pract 2011; 93: 56-62.
39. Raz I, Wilson PW, Strojek K, et al.: Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial. Diabetes Care 2009; 32: 381-386.
44
45
46
47
48
49
50
51
10
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
References_xml – ident: 29
  doi: 10.1007/s13340-010-0006-7
– ident: 2
  doi: 10.1016/S0140-6736(98)00090-7
– ident: 48
  doi: 10.1186/1476-511X-8-41
– ident: 11
  doi: 10.1385/ENDO:29:1:143
– ident: 27
  doi: 10.1016/S0045-6535(99)00296-9
– ident: 23
  doi: 10.1046/j.1365-2362.30.s2.2.x
– ident: 50
  doi: 10.1016/S0168-8227(01)00353-9
– ident: 37
  doi: 10.1161/ATVBAHA.107.152835
– ident: 7
  doi: 10.1074/jbc.R400019200
– ident: 31
– ident: 5
  doi: 10.2337/diacare.19.3.257
– ident: 22
  doi: 10.1111/j.1447-0594.2005.00282.x
– ident: 32
  doi: 10.1002/(SICI)1520-7560(200003/04)16:2<125::AID-DMRR90>3.0.CO;2-4
– ident: 36
  doi: 10.1016/S0140-6736(98)12131-1
– ident: 38
  doi: 10.1210/jc.2005-1566
– ident: 26
– ident: 44
  doi: 10.1161/hc0502.103333
– ident: 34
  doi: 10.2337/db08-0063
– ident: 18
  doi: 10.5551/jat.E538
– ident: 25
  doi: 10.1111/j.1447-0594.2008.00465.x
– ident: 9
  doi: 10.1152/ajpheart.01332.2008
– ident: 4
  doi: 10.1016/0002-8703(87)90635-1
– ident: 6
  doi: 10.1056/NEJM199505043321804
– ident: 30
– ident: 39
  doi: 10.2337/dc08-1671
– ident: 17
  doi: 10.5551/jat.E265
– ident: 42
  doi: 10.1007/s00125-009-1574-6
– ident: 14
  doi: 10.1016/j.ejphar.2011.02.044
– ident: 15
  doi: 10.1001/jama.295.14.1681
– ident: 33
  doi: 10.1038/414813a
– ident: 40
– ident: 10
  doi: 10.1016/j.freeradbiomed.2010.09.006
– ident: 49
  doi: 10.1111/j.1365-2265.2007.03099.x
– ident: 8
  doi: 10.1016/0026-0495(94)90039-6
– ident: 43
  doi: 10.1016/j.bbrc.2006.09.039
– ident: 45
  doi: 10.1111/j.1464-5491.2005.01647.x
– ident: 41
  doi: 10.1111/j.1463-1326.2009.01037.x
– ident: 16
  doi: 10.1177/193229681100500112
– ident: 19
  doi: 10.1007/s13340-010-0006-7
– ident: 20
– ident: 51
  doi: 10.2337/diacare.28.10.2465
– ident: 1
  doi: 10.1056/NEJM199309303291401
– ident: 3
  doi: 10.2337/diabetes.54.6.1615
– ident: 24
  doi: 10.2337/diacare.26.3.881
– ident: 47
  doi: 10.1016/j.archger.2009.09.022
– ident: 35
  doi: 10.1007/s00125-004-1334-6
– ident: 21
  doi: 10.1507/endocrj.K11E-114
– ident: 28
  doi: 10.1016/S0300-483X(00)00231-6
– ident: 13
  doi: 10.1016/j.atherosclerosis.2010.04.024
– ident: 46
  doi: 10.1007/s11745-011-3539-z
– ident: 12
  doi: 10.1016/j.diabres.2010.11.030
SSID ssj0033556
Score 1.9608738
Snippet Aims: This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs)...
This study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs) in...
AIMSThis study aimed to evaluate the relationship between improvement of glucose metabolism and plasma levels of diacron-reactive oxygen metabolites (d-ROMs)...
SourceID proquest
crossref
pubmed
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 200
SubjectTerms Adult
Aged
Aged, 80 and over
and postprandial glucose
Area Under Curve
Blood Glucose - metabolism
daily profile of plasma glucose
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - metabolism
diacron-reactive oxygen metabolites
Fasting
Female
Humans
Male
Middle Aged
Oxidative Stress
Postprandial Period
Reactive Oxygen Species
Regression Analysis
type 2 diabetes
Title Improving in the Fasting, but Not the Postprandial, Glucose Level is Associated with Reduction of Plasma d-ROMs Level in Patients with Type 2 Diabetes
URI https://www.jstage.jst.go.jp/article/jnms/80/3/80_200/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/23832404
https://search.proquest.com/docview/1399058004
Volume 80
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Journal of Nippon Medical School, 2013, Vol.80(3), pp.200-210
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKQGgviDvlJiONpy4ltXN9RLBpoLWTWCv1LXISZ2Rdk6hxHugP4afw-ziOHTeITRq8RFUSO1HO15PvOOd8B6EDl4aJy4hjMc9zLQCFawUZ8SzfsdMk5SSetJL505l3snC-Lt3lYPCrl7XUiHicbK-tK_kfq8I-sKuskv0Hy5pJYQf8BvvCFiwM21vZeLcioLMVM1YL3aQkbsSoKIUqhSprUW1kAUsr7z_q8tSvZMaQbGnOtJG6XPSNFHTtuGQFBHvNRqn17Wxad2OMImt97VLuDZx3lldVufs6pCVA39PP3ZEvKwZAzC_Yqhlt4a6-52YVWCpLq-qiVSnK3YcAYLdwTV1jJNjGHDpvto1qyj1nom5-mBfQOV_l63zb6DFWnujL6NUPVbY65spXUwf8o2OHfWeu2kJp0NK-Z7bt3kueqFzav94fxJd6tJfFuh4H9tiM6at0z86i48XpaTQ_Ws7voLtECgzKIvOlSS2iwOE8XQsKE37oTfcH-7l3CQHABb85tmk5zvwheqANhT8qpD1CA148RvenOv3iCfppAIfzAgOysAbcIQa4YYBbu7MPt0OswYZb4OC8xjuwYQkdbMCGywwrsGEFtm5MgTuwqRESbJjgDmxP0eL4aP7pxNKNPawEuJCwfJfZUjgy5uDHvDRLbRYGwKRiQhnw18T22SRlHic0m6SuQ3noZYmXuNRxaUwDnz5De0VZ8BcIZxB-yL5J2YQkUjswBMLtJxnENR4E6iEZooPugUeV0m-JZNwLdomkXaLAlp1Yh8hXxjAn6T-1OYnqM80BWRUJTmiI3nXWi8Azy89trOBlU0dwD6HtQkDmDNFzZVYzOxBlqYTpvLzF6Fdon7Q9WOS632u0JzYNfwNMWMRvW9j9BmPPvxE
link.rule.ids 315,783,787,4033,27937,27938,27939
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Improving+in+the+fasting%2C+but+not+the+postprandial%2C+glucose+level+is+associated+with+reduction+of+plasma+d-ROMs+level+in+patients+with+type+2+diabetes&rft.jtitle=Journal+of+Nippon+Medical+School+%3D+Nippon+Ika+Daigaku+zasshi&rft.au=Ohara%2C+Makoto&rft.au=Watanabe%2C+Kentaro&rft.au=Suzuki%2C+Tatsuya&rft.au=Sekimizu%2C+Ken-ichi&rft.date=2013&rft.eissn=1347-3409&rft.volume=80&rft.issue=3&rft.spage=200&rft.epage=210&rft_id=info:doi/10.1272%2Fjnms.80.200&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1345-4676&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1345-4676&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1345-4676&client=summon